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Executive Summary 
This report contains individual radiological protection surveillance data developed during 
2006 for adult members of a select group of families living on Utrōk Atoll. These Group I 
volunteers all underwent a whole-body count to determine levels of internally deposited cesium-
137 (137Cs) and supplied a bioassay sample for analysis of plutonium isotopes. Measurement 
data were obtained and the results compared with an equivalent set of measurement data for 
137Cs and plutonium isotopes from a second group of adult volunteers (Group II) who were long-
term residents of Utrōk Atoll. For the purposes of this comparison, Group II volunteers were 
considered representative of the general population on Utrōk Atoll. The general aim of the study 
was to determine residual systemic burdens of fallout radionuclides in each volunteer group, 
develop data in response to addressing some specific concerns about the preferential uptake 
and potential health consequences of residual fallout radionuclides in Group I volunteers, and 
generally provide some perspective on the significance of radiation doses delivered to volunteers 
(and the general Utrōk Atoll resident population) in terms of radiological protection standards and 
health risks. 
Based on dose estimates from measurements of internally deposited 137Cs and plutonium 
isotopes, the data and information developed in this report clearly show that neither volunteer 
group has acquired levels of internally deposited fallout radionuclides specific to nuclear 
weapons testing in the Marshall Islands that are likely to have any consequence on human 
health. Moreover, the dose estimates are well below radiological protection standards as 
prescribed by U.S. regulators and international agencies, and are very small when compared to 
doses from natural sources of radiation in the Marshall Islands and the threshold where radiation 
health effects could be either medically diagnosed in an individual or epidemiologically discerned 
in a group of people.  
In general, the results from the whole-body counting measurements of 137Cs are consistent 
with our knowledge that a key pathway for exposure to residual fallout contamination on Utrōk 
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Atoll is low-level chronic uptake of 137Cs from the consumption of locally grown produce 
(Robison et al., 1999). The error-weighted, average body burden of 137Cs measured in Group I 
and Group II volunteers was 0.31 kBq and 0.62 kBq, respectively. The associated average, 
annual committed effective dose equivalent (CEDE) delivered to Group I and Group II volunteers 
from 137Cs during the year of measurement was 2.1 and 4.0 mrem. For comparative purposes, 
the annual dose limit for members of the public as recommended by the National Council on 
Radiation Protection and Measurements (NCRP) and the International Commission on 
Radiological Protection (ICRP) is 100 mrem. Consequently, specific concerns about elevated 
levels of 137Cs uptake and higher risks from radiation exposure to Group I volunteers would be 
considered unfounded. Moreover, the urinary excretion of plutonium-239 (239Pu) from Group I 
and Group II volunteers is statistically indistinguishable. In this case, the error-weighted, average 
urinary excretion of 239Pu from Group I volunteers of 0.10 μBq per 24-h void with a range 
between −0.01 and 0.23 μBq per 24-h void compares with an error-weighted average from 
Group II volunteers of 0.11 μBq per 24-h void with a range between −0.20 and 0.47 μBq per 24-
h void. The range in urinary excretion of 239Pu from Utrōk Atoll residents is very similar to that 
observed for other population groups in the Marshall Islands (Bogen et al., 2006; Hamilton et al., 
2006a; 2006b; 2006c, 2007a; 2007b; 2007c) and is generally considered representative of 
worldwide background. 
The corresponding average CEDE delivered to Group I volunteers from internally deposited 
137Cs and 239Pu is estimated to be around 2.1 mrem and 1.2 mrem, respectively. The total 
CEDE (i.e., 3.3 mrem for the current year of measurement) is therefore very small when 
compared to the threshold where radiation health effects could be either medically diagnosed in 
an individual or epidemiologically discerned in a group of people. Of significance and perhaps 
most importantly, Group I volunteers from the special interest group1 of families identified above 
can be assured that the measurement data contained in this report and the continuing 
radiological protection monitoring program clearly show that they have not acquired levels of 
internally deposited fallout radionuclides that are likely to have any consequence on human 
health. It is also of interest to note that the total dose based on estimates of internally deposited 
137Cs and 239Pu in Group I volunteers (i.e., 3.3 mrem CEDE for the current year of 
measurement) is well below the annual safety standard of 15 mrem as imposed by the Marshall 
Islands Nuclear Claims Tribunal (NCT). The same would be true even if we were to consider the 
                                                 
1 A group of family members identified by community leaders as potential program participants and constituted all 
the Group I volunteers. 
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uncertainty and variability in dose estimates. For example, previous studies show that the upper 
and lower 95% confidence limits on inter-individual variability in dose estimates based on 
environmental data typically lie within a ~threefold factor of the population average value (Bogen 
et al., 1997). We have demonstrated that this is also largely true of the variability seen in dose 
estimates based on direct measurements of internally deposited radionuclides. This would imply 
that the CEDE delivered to Group I volunteers could range from 1 to 9 mrem where the 
maximum estimated CEDE of 9 mrem is still less than the 15 mrem annual safety standard 
adopted by the NCT. Moreover, while this comparative study is limited to adult volunteers, dose 
estimates for the general population on Utrōk Atoll that include children, teenagers and adults 
from both sexes will likely fall within a similar range. Any further conjecture about current and 
potential future radiation risks to the resident population from radiation exposure can be most 
rigorously assessed by continuation of the radiological protection monitoring program. 
Background 
This preliminary report contains 
comparative individual radiological protection 
surveillance data for Utrōk Atoll residents 
obtained from whole body counting and 
plutonium bioassay. Measurements of 
internally deposited 137Cs and plutonium 
isotopes are compared between two groups 
of adult volunteers. Local atoll government 
representatives identified an initial group of 
potential candidates (N=8) for participation in 
the radiological surveillance monitoring 
program based on expressions of concern 
that these families had been exposed to 
elevated levels of fallout contamination in the 
environment. The second group of 
volunteers (N=12) from Utrōk Atoll was used 
as a comparison group and simply 
represented the next subgroup of volunteers 
from Utrōk Atoll who expressed interest in 
participating in the program. The primary 
selection criterion for Group II program 
participation was a requirement that all 
volunteers should be long-term residents of 
Utrōk Atoll so that they could be considered 
as representative of the general population. 
A total of 12 adult volunteers participated in 
this second phase of the program but we 
were unable to obtain a whole-body count 
from one individual. All volunteers had to be 
willing to travel to Majuro Atoll to receive a 
whole-body count and provide a 24-h (urine) 
void bioassay sample. 
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Methodology 
A full description of the radiological 
surveillance monitoring program on Utrōk 
Atoll can be found elsewhere (Hamilton et 
al., 2007d). Whole-body counts and 
plutonium bioassay measurements were 
performed on Group I and Group II 
volunteers at different times but using 
identical, standardized procedures. The 
Utrōk whole-body counting facility and 
plutonium bioassay collection program are 
based on Majuro Atoll because of the lack of 
infrastructure support on Utrōk Atoll. As a 
consequence, program volunteers were all 
required to travel to Majuro Atoll and stay at 
a local hotel until the necessary 
arrangements could be made for each 
volunteer to receive a whole-body count and 
provide a 24-h (urine) void sample for 
bioassay. Travel and accommodation were 
provided at no expense to the volunteers. 
The hotel also served as the main collection 
point where bioassay samples could be 
collected under a relatively clean and 
controlled environment. The whole-body 
counting operation and plutonium bioassay 
collections were conducted by trained 
Marshallese technicians based on 
documented procedures developed by 
researchers from the Lawrence Livermore 
National Laboratory (LLNL). The bioassay 
samples were then taken to the Majuro 
whole-body counting facility, stabilized by 
addition of acid, and shipped to the 
Lawrence Livermore National Laboratory for 
analysis by accelerator mass spectrometry 
(AMS) (Hamilton et al., 2004; 2007d) 
The most abundant isotopes of 
plutonium in radioactive debris generated 
from nuclear weapons testing are 239Pu and 
plutonium-240 (240Pu).The relative sensitivity 
of mass spectrometry for low-level 
determination of activity concentrations of 
239Pu and 240Pu in bioassay samples will 
depend on several factors including the 
specific activity and relative abundance of 
the isotopes concerned. Based on the mass 
spectrometric measurements developed for 
this report, the estimated Minimal Detectable 
Amount (MDA) for 239Pu and 240Pu was 
about 0.4 and 1.0 μBq, respectively. We 
have therefore largely limited our discussion 
of results to higher precision measurements 
of 239Pu but include both isotopes in data 
tables. The 240Pu/239Pu atom ratio measured 
in surface soil samples from Utrōk Atoll 
average around 0.27 (Hamilton, 2007e) and 
compare with an average reported 
240Pu/239Pu atom ratio in integrated 
worldwide-fallout deposition of 0.18 (Krey et 
al., 1976). The corresponding 240Pu/239Pu 
ratios expressed on an activity basis are 
0.66 and 1.0, respectively. This implies that 
dose estimates for Group I and II volunteers 
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may be as much as twice the values based 
exclusively on urinary excretion of 239Pu. 
The Marshall Islands Radiological 
Surveillance Monitoring Program (MIRSMP) 
is approved by the Human Subjects 
Committee of the Institutional Review Board 
at the Lawrence Livermore National 
Laboratory. Moreover, the quality assurance 
requirements for the operation of whole-body 
counting facilities in the Marshall Islands, 
and for the collection and measurement 
plutonium in bioassay samples, have been 
designed to conform with standard 
requirements of the United States (U.S.) 
Department of Energy Laboratory 
Accreditation Program (DOELAP) for 
occupational monitoring of DOE workers 
(Hamilton et al., 2007c; Kehl et al., 2007). 
The use of AMS for low-level plutonium 
bioassay measurements has also been 
independently validated by the U.S. National 
Institute of Standards and Technology 
(NIST) (McCurdy et al., 2004). 
Results and Discussion 
The results of whole-body counting 
measurements of internally deposited 137Cs 
in the Group I and Group II volunteers are 
shown in Table 1. With the exception of one 
individual from Group I, a small but 
measurable quantity of internally deposited 
137Cs was observed in all program 
volunteers. A number of other whole-body 
counting measurements of internally 137Cs 
are at or below the MDA above which a 
determination can be made with reasonable 
confidence that 137Cs would otherwise 
actually be present. Generally, Marshall 
Islanders are potentially exposed to 
elevated levels of residual fallout 
contamination in the environment and so, 
for program volunteers living on Utrōk Atoll, 
it was not unusual to find measurable 
quantities of 137Cs in the vast majority of 
program participants (Hamilton et al., 
2007d). 
The error-weighted, average internally 
deposited 137Cs in Group I volunteers of 
0.31 kBq (N=8) compares with an error-
weighted average of 0.62 kBq (N=11) in 
Group II volunteers. Based on the results 
presented in this report, Group I program 
volunteers have actually acquired, on 
average, slightly lower levels of 137Cs 
compared with the general population living 
on Utrōk Atoll. Consequently, specific 
concerns about elevated levels of 137Cs 
uptake and higher risks from radiation 
exposure to Group I volunteers would be 
considered unfounded. For further 
comparative purposes, between 2005 and 
2006 over 100 whole-body counts were 
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Table 1. Internally deposited 137Cs activity (kBq ± 1 SD) in Group I and Group II volunteers from 
Utrōk Atoll in the Marshall Islands. 
137Cs (kBq) 
Personal ID Age Type Sex Collection Date 
value MDA 
              
Group I Volunteers     
UT00160 Adult Male 2006-03-21 0.56 ± 0.07 0.32 
UT00212 Adult Female 2006-03-21 0.00 ± 0.05# 0.11 
UT00213 Adult Female 2006-03-21 0.10 ± 0.04 0.20 
UT00214 Adult Female 2006-03-21 0.21 ± 0.07 0.33 
UT00215 Adult Female 2006-03-21 0.41 ± 0.07 0.32 
UT00216 Adult Male 2006-03-21 0.67 ± 0.07 0.31 
UT00217 Adult Male 2006-03-21 0.63 ± 0.08 0.33 
UT00218 Adult Male 2006-03-21 0.56 ± 0.07 0.30 
 error-weighted average = 0.32 kBq  
Group II Volunteers      
UT00012 Adult Male 2006-10-25 0.48 ± 0.07 0.30 
UT00029 Adult Male 2006-10-25 1.41 ± 0.09 0.34 
UT00034 Adult Male 2006-10-25 1.06 ± 0.09 0.38 
UT00058 Adult Male 2006-10-25 0.71 ± 0.07 0.32 
UT00061 Adult Male 2006-07-12 0.52 ± 0.06 0.28 
UT00186 Adult Male 2006-10-25 1.07 ± 0.09 0.36 
UT00189 Adult Male 2006-10-26 0.83 ± 0.09 0.37 
UT00226 Adult Female 2006-07-10 0.10 ± 0.04 0.20 
UT00248 Adult Male 2006-10-25 0.68 ± 0.08 0.35 
UT00249 Adult Male 2006-10-25 0.83 ± 0.08 0.34 
UT00250 Adult Male 2006-10-25 0.93 ± 0.09 0.38 
  error-weighted average = 0.62 kBq   
# the uncertainty in the measurement was given a value equating to half the Minimum Detectable 
Amount (MDA), i.e., MDA/2 
 
performed on Utrōk Atoll residents 
(including non-members of the Utrōk Atoll 
population group) (Hamilton et al., 2007d). 
The error-weighted, population-average 
137Cs body burden based on these 
measurements was 0.46±0.04 kBq. The 
associated population-average, annual 
CEDE contribution from 137Cs is estimated 
to be around 3.5 mrem (Hamilton et al., 
2007d). The estimated CEDE from 137Cs for 
Group I volunteers was slightly less, and 
averaged around 2.1 mrem with a maximum 
individual dose of 3.4 mrem. For 
comparative purposes, the CEDE 
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contribution from internally deposited 137Cs 
in the Group II volunteers during the year of 
measurement was 4.0 mrem. 
Residents of the Northern Hemisphere 
are all expected to acquire a small systemic 
burden of plutonium from general exposure 
to worldwide-fallout contamination to 
produce daily urinary excretion rates of 
around 2-4 μBq (Boecker et al., 1991). In the 
northern Marshall Islands, long-term chronic 
exposure to local or regional fallout 
contamination and significant incremental 
intakes of plutonium associated with specific 
activities may increase the urinary excretion 
of plutonium over that expected from 
exposure to worldwide-fallout contamination. 
The results of the plutonium bioassay 
measurements on Group I and Group II 
volunteers are shown in Table 2. The 
methodologies employed at LLNL for 
plutonium bioassay are extremely sensitive. 
While we were able to confirm the presence 
of trace amounts of 239Pu in bioassay 
samples collected from Utrōk Atoll 
volunteers, the levels were barely detectable 
above our field-blank control samples (Table 
2). None of the bioassay samples contained 
reported 240Pu concentrations above the 
measurement MDA. In general, the results 
clearly demonstrate that none of the 
volunteers have acquired residual systemic 
burdens of plutonium in excess of historical 
estimates of urinary excretion of plutonium 
(Boecker et al., 1991) based systemic 
burdens of plutonium acquired from general 
exposure to worldwide fallout contamination 
in the Northern Hemisphere. 
The error-weighted, average urinary 
excretion of 239Pu from Group I volunteers 
was 0.10 μBq per 24-h void with a range 
between −0.01 and 0.23 μBq per 24-h. This 
compares with an error-weighted, average 
urinary excretion of 239Pu from Group II 
volunteers of 0.11 μBq per 24-h void with a 
range between −0.20 and 0.47 μBq per 24-h 
void. The average urinary excretion of 
plutonium from these two groups is 
statistically indistinguishable and provide 
further evidence that Group I volunteers 
have not acquired residual systemic burdens 
of fallout radionuclides that would be 
considered in excess of Group II volunteers. 
Moreover, plutonium has a relatively long 
biological half-life of 20 to 50 years. 
Systemic plutonium acquired from previous 
exposures will be very slowly removed from 
the body, which occurs primarily in urine and 
with a long-term excretion coefficient of ~2 
×10-5 of the systemic burden per day. 
Therefore, the low-level urinary excretion of 
plutonium from Utrōk Atoll residents also 
implies that the program volunteers have 
never acquired a significant systemic burden 
of plutonium. 
Under steady-state conditions (Daniels et 
al., 2007), the urinary excretion of 239Pu from 
Group I and Group II volunteers yield 
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systemic burdens of 239Pu that equate to 
annual doses of around 24 μrem and 26 
μrem (where 1 μrem = 0.001 mrem), 
respectively, or an annual CEDE of 1.2 
mrem and 1.3 mrem, respectively. Even 
taking into account a doubling of the 
estimated dose from undetectable systemic 
burdens of 240Pu, we conclude that the dose 
contribution from plutonium is very low and 
represents a very small fraction of the dose 
received from natural background radiation 
in the Marshall Islands. 
Conclusion
During March of 2006, a small number of 
adults from a select group of families living 
on Utrōk Atoll participated in the MIRSMP 
using facilities located on Majuro Atoll. 
These Group I volunteers all underwent 
whole-body counting to determine levels of 
internally deposited 137Cs and supplied a 
urine bioassay sample for analysis of 
plutonium isotopes. Measurement data were 
obtained and the results compared with an 
equivalent set of measurement data for 
137Cs and plutonium isotopes from a second 
group of adult volunteers (Group II) who 
were long-term residents of Utrōk Atoll. 
Based on measurements of internally 
deposited 137Cs and plutonium isotopes, the 
dosimetric data and information developed in 
this report clearly show that neither volunteer 
group acquired levels of internally deposited 
fallout radionuclides specific to nuclear 
weapons testing in the Marshall Islands that 
are likely to have any consequence on 
human health.  
The total annual average CEDE 
delivered to Group I volunteers from 
internally deposited 137Cs and 239Pu was 
estimated to be 3.3 mrem. The dose limit for 
members of the public currently 
recommended by the NCRP and the ICRP, 
and adopted in the Basic Safety Standards 
(FAO et al., 1996), is 100 mrem per year. 
The same numeric dose limit for protection 
of the public is specified by the U.S. Nuclear 
Regulatory Commission (NRC) under 10 
CFR Part 20 (NRC, 1994). In order to ensure 
that the dose limit will be met, dose 
constraints on individual sources and/or 
practices are often established at a fraction 
of the dose limit (ICRP, 1991; NCRP, 1993) 
such as those applied to remediation of 
radioactive contamination at licensed 
facilities under the License Termination Rule 
(LTR) 10 CFR Part 20, Subpart E (NRC, 
2004). For example, a site may be 
considered acceptable for unrestricted use if 
the total annual effective dose equivalent 
(TEDE; a form of CEDE) from all exposures 
does not exceed 25 mrem above normal 
background and concentrations of residual 
radioactive material have been reduced to 
levels as low as reasonably achievable 
(ALARA). Annual dose criterion for cleanup 
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of radioactively contaminated sites or, as in 
this case, the TEDE, usually refer to the sum 
of the deep-dose equivalent from external 
exposures during the year of measurement 
and the 50-y CEDE from intakes of 
radionuclides during that year. 
An alternative approach to gaining some 
perspective on the radiation dose estimates 
is to present the results in terms of individual 
risk. The U.S. Environmental Protection 
Agency (EPA) uses a risk-based approach to 
remediation of radioactively contaminated 
sites based on excess lifetime risks of fatal 
cancer and cancer incidence. The EPA uses 
a lifetime cancer risk criterion with an upper 
bound of 10−4 and provides guidance that an 
annual effective dose equivalent of 15 mrem 
or less would normally comply with the risk 
goal. The doses delivered to volunteers from 
Utrōk Atoll equate to an excess lifetime risk 
of fatal cancer of around 1 ×10−4 or 0.01% (1 
in 10,000 exposed individuals). This may be 
compared to the excess fatal cancer risk 
from background radiation in the Marshall 
Islands of around 5 ×10−3 or 0.5% (5 per 
1000 exposed individuals) and is a very 
small fraction of the underlying lifetime risk 
of death from cancer in the United States of 
around 25%. It should also be noted that 
under the current system for radiological 
protection, practices giving rise to annual 
effective doses of less than 1 mrem are 
commonly exempted from regulatory 
requirements on the basis that the doses are 
so small that they can be considered 
negligible (IAEA, 1988) and the excess 
lifetime risk of fatal cancer de minimis. 
Based on measurements of internally 
deposited 137Cs and 239Pu, the average 
dose delivered to Group I and Group II 
volunteers from Utrōk Atoll easily satisfy the 
100 mrem annual dose criterion (above 
background and described above) for 
protection of members of the public and 
more closely approximates doses that are so 
small they are considered trivial and exempt 
from further consideration. This assertion is 
made on the basis that 137Cs is known to be 
a major contributor to the total manmade 
dose in the Marshall Islands with a less 
significant contribution from plutonium 
isotopes. However, no consideration has 
been given to the external dose contribution 
or the CEDE from potential intakes of other 
fallout radionuclides such as strontium-90 
(90Sr). 
In general, radiological protection 
standards provide a very conservative 
approach to protecting public health and the 
environment. The dose estimates presented 
in this report are already well below radiation 
safety standards as recommended by U.S. 
regulators and the community of 
international agencies, and are very small 
when compared to the threshold where 
radiation health effects could be either 
medically diagnosed in an individual or 
epidemiologically discerned in a group of 
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people. Nonetheless, the observed 
incidence of cancer and other diseases is 
changing throughout the world including the 
Pacific Island nations. These changes may 
simply reflect improved screening and 
registration procedures but could also result 
from changes in lifestyle including diet or 
other personal habits (e.g., cigarette 
smoking), population migration, and 
increased environmental exposure to 
harmful chemicals including radioactive and 
non-radioactive substances. However, based 
on albeit limited radiological surveillance 
monitoring data developed to date under the 
MIRSMP, we can provide assurances to the 
local resident population and the global 
community that levels of exposure to 
radioactive fallout contamination on Utrōk 
Atoll are very low and are likely to have no 
discernible impact on human health, and that 
it is most unlikely that any additional cancer 
fatalities above those normally expected will 
arise which can be directly attributable to 
current radiological exposure conditions on 
the atoll. 
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Table 2. Internally deposited plutonium activity (μBq ± 1 SD) in Group I and Group II volunteers 
from Utrōk Atoll in the Marshall Islands. 
μBq per 24 h void 
ID# Age Type Gender Collection Date 239Pu 240Pu 
Group I Volunteers
UT00160 Adult Male 22-Mar-06 0.16 ± 0.24 -0.17 ± 0.57 
UT00212 Adult Female 24-Mar-06 -0.01 ± 0.17 -0.17 ± 0.50 
UT00213 Adult Female 22-Mar-06 0.21 ± 0.21 -0.17 ± 0.36 
UT00214 Adult Female 22-Mar-06 0.19 ± 0.20 0.12 ± 0.35 
UT00215 Adult Female 22-Mar-06 0.06 ± 0.18 0.18 ± 0.40 
UT00216 Adult Male 22-Mar-06 0.13 ± 0.19 -0.17 ± 0.37 
UT00217 Adult Male 22-Mar-06 0.23 ± 0.24 -0.17 ± 0.50 
UT00218 Adult Male 22-Mar-06 0.00 ± 0.15 -0.17 ± 0.31 
 error-weighted average = 0.10 -0.08 
Group II Volunteers
UT00012 Adult Male 23-Oct-06 0.30 ± 0.23 -0.16 ± 0.37 
UT00029 Adult Male 23-Oct-06 0.47 ± 0.31 0.33 ± 0.50 
UT00034 Adult Male 23-Oct-06 0.34 ± 0.25 0.17 ± 0.40 
UT00058 Adult Male 23-Oct-06 0.35 ± 0.25 0.16 ± 0.38 
UT00061 Adult Male 23-Oct-06 0.05 ± 0.18 0.44 ± 0.48 
UT00062 Adult Male 23-Oct-06 0.05 ± 0.19 0.13 ± 0.36 
UT00186 Adult Male 23-Oct-06 0.39 ± 0.25 -0.16 ± 0.37 
UT00189 Adult Male 23-Oct-06 0.20 ± 0.26 -0.16 ± 0.52 
UT00226 Adult Female 23-Oct-06 -0.20 ± 0.16 -0.16 ± 0.45 
UT00248 Adult Male 23-Oct-06 0.03 ± 0.17 0.10 ± 0.34 
UT00249 Adult Male 23-Oct-06 -0.04 ± 0.16 -0.16 ± 0.36 
UT00250 Adult Male 23-Oct-06 0.46 ± 0.32 0.76 ± 0.69 
 error-weighted average = 0.11 0.05 
Process Field Blanks#       
Field Blank not applicable 24-Mar-06 -0.06 ± 0.14 -0.17 ± 0.33 
Field Blank not applicable 24-Mar-06 0.00 ± 0.15 0.09 ± 0.32 
Field Blank not applicable 28-Mar-06 0.00 ± 0.15 -0.17 ± 0.31 
Field Blank not applicable 28-Mar-06 -0.06 ± 0.14 -0.17 ± 0.34 
Field Blank not applicable 11-Aug-06 0.13 ± 0.20 -0.16 ± 0.36 
Field Blank not applicable 11-Aug-06 0.06 ± 0.17 0.15 ± 0.35 
Field Blank not applicable 11-Aug-06 -0.05 ± 0.16 -0.16 ± 0.34 
  error-weighted average = -0.01 -0.09 
#
Process field blanks were collected in the Marshall Islands and handled in exactly the same manner as bioassay 
samples. The results provide a measure of the background concentration of plutonium introduced as part of 
sample handling and analysis procedures. 
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